Abstract
The blood-brain barrier (BBB) mediates interactions between the brain and the cytokines produced in the periphery. Some of these cytokines play significant roles in feeding behavior. This review will summarize various ways by which cytokines cross the BBB and discuss the implications of their transport systems in feeding. For simplicity of discussion, three categories of cytokines are discussed: (1) the proinflammatory cytokines TNFα, IFNγ, IL1, and IL6, (2) the chemokines MIP-1, CINC-1 and IL8, and (3) other cytokines (LIF, CNTF, GM-CSF, FGF, EGF, and TGFα). The pharmacokinetics of barrier penetration, compartmental distribution, stability, and mechanism of passage (presence or absence of saturable transport) are summarized. Our understanding of cytokines interacting with the BBB is still growing, not only are more cytokines being studied, but also more details of the nature of the transport systems and how they affect feeding behavior are being explored.
Keywords: Cytokines, chemokines, pharmacokinetics
Current Pharmaceutical Design
Title: Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding
Volume: 9 Issue: 10
Author(s): Weihong Pan and Abba J. Kastin
Affiliation:
Keywords: Cytokines, chemokines, pharmacokinetics
Abstract: The blood-brain barrier (BBB) mediates interactions between the brain and the cytokines produced in the periphery. Some of these cytokines play significant roles in feeding behavior. This review will summarize various ways by which cytokines cross the BBB and discuss the implications of their transport systems in feeding. For simplicity of discussion, three categories of cytokines are discussed: (1) the proinflammatory cytokines TNFα, IFNγ, IL1, and IL6, (2) the chemokines MIP-1, CINC-1 and IL8, and (3) other cytokines (LIF, CNTF, GM-CSF, FGF, EGF, and TGFα). The pharmacokinetics of barrier penetration, compartmental distribution, stability, and mechanism of passage (presence or absence of saturable transport) are summarized. Our understanding of cytokines interacting with the BBB is still growing, not only are more cytokines being studied, but also more details of the nature of the transport systems and how they affect feeding behavior are being explored.
Export Options
About this article
Cite this article as:
Pan Weihong and Kastin J. Abba, Interactions of Cytokines with the Blood-Brain Barrier: Implications for Feeding, Current Pharmaceutical Design 2003; 9 (10) . https://dx.doi.org/10.2174/1381612033455332
DOI https://dx.doi.org/10.2174/1381612033455332 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epigenetic Control of Hypertension by DNA Methylation: A Real Possibility
Current Pharmaceutical Design Emerging Therapeutic Targets and Agents for Glioblastoma Migrating Cells
Anti-Cancer Agents in Medicinal Chemistry Receptor-Independent Effects of Endocannabinoids on Ion Channels
Current Pharmaceutical Design A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients
Current Pharmaceutical Design Current Options in the Treatment of Mast Cell Mediator-Related Symptoms in Mastocytosis
Inflammation & Allergy - Drug Targets (Discontinued) Targeting of Cancer-Related Proteins with PNA Oligomers
Current Cancer Drug Targets Bioactive Peptides - Are There More Antihypertensive Mechanisms Beyond ACE Inhibition?
Current Pharmaceutical Design Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19
Current Drug Delivery Synaptic Activity-Regulated Wnt Signaling in Synaptic Plasticity, Glial Function and Chronic Pain
CNS & Neurological Disorders - Drug Targets Toll-Like Receptor Agonists as Adjuvants for HIV Vaccines
Current Medicinal Chemistry Participation of Adult Bone Marrow-Derived Stem Cells in Pancreatic Regeneration: Neogenesis Versus Endogenesis
Current Stem Cell Research & Therapy Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
Current Drug Targets - Cardiovascular & Hematological Disorders Sclerosing Polidocanol Injections of Small Vessels to Treat the Chronic Painful Tendon
Cardiovascular & Hematological Agents in Medicinal Chemistry Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis
Anti-Cancer Agents in Medicinal Chemistry Sesamin and Sesamolin: Natures Therapeutic Lignans
Current Enzyme Inhibition HIV-1 Capsid Inhibitors as Antiretroviral Agents
Current HIV Research Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Arachidonic Acid Signaling in Pathogenesis of Allergy: Therapeutic Implications
Current Drug Targets - Inflammation & Allergy